DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Humatrope (Somatropin) - Pituitary Tumour Recurrent - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pituitary Tumour Recurrent (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Humatrope (Somatropin) where reactions include pituitary tumour recurrent. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Humatrope side effects in 77 year old female

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: 77 year old female, weighing 69.8 kg (153.7 pounds)

Reactions: Pituitary Tumour Recurrent

Drug(s) suspected as cause:
Humatrope



Possible Humatrope side effects in 35 year old female

Reported by a physician from Japan on 2012-05-24

Patient: 35 year old female

Reactions: Pituitary Tumour Recurrent

Drug(s) suspected as cause:
Humatrope



Possible Humatrope side effects in female

Reported by a physician from United States on 2012-03-30

Patient: female

Reactions: Pituitary Tumour Recurrent

Drug(s) suspected as cause:
Humatrope



Possible Humatrope side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: female

Reactions: Visual Impairment, Pituitary Tumour Recurrent

Drug(s) suspected as cause:
Humatrope



Possible Humatrope side effects in male

Reported by a physician from United States on 2012-03-23

Patient: male

Reactions: Colonic Polyp, Intentional Overdose, Insulin-Like Growth Factor Increased, Pituitary Tumour Recurrent, Self-Medication, Benign Neoplasm of Prostate

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Humatrope
    Dosage: 0.6 -0.8 mg

Humatrope
    Dosage: 0.2 - 0.4 mg, qd
    Indication: Hypopituitarism



Possible Humatrope side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-13

Patient: male

Reactions: Colonic Polyp, Intentional Overdose, Pituitary Tumour Recurrent, Insulin-Like Growth Factor Increased, Self-Medication, Benign Neoplasm of Prostate

Drug(s) suspected as cause:
Humatrope
    Dosage: 0.2 - 0.4 mg, qd
    Indication: Hypopituitarism

Humatrope
    Dosage: 0.6 -0.8 mg

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017